ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Peagler Heads AACE, Myers Is Presidents Elect; Bottiglieri Retires, Fink To Replace Him At ACS

January 6, 1984

In Radio Address, Clinton Outlines Administration Priorities

October 2, 1998

NCCS Networker Volume 9 Issue 1, Spring 1995

April 13, 1995

NIH To Replace RAC With New Committee

July 19, 1996

Pao Named Director of Department Of Hematology And Oncology At Vanderbilt University

September 30, 2011

NCI-Approved Clinical Trials

January 26, 2007